Liver cancer due to hepatitis B
4Curable or preventable in mostAI-generated
Vaccine is the milestone that makes most hepatitis B liver cancer preventableAI-generated
Burden-over-time charts — how many people this disease affects and whether that number is rising or falling — are coming to this page. The treatability read, milestones, and live trial pipeline below are current.
What's being tested now
No registered interventional trials matched to this cause yet.
Where we are
AI-generatedLiver cancer due to hepatitis B is curable or preventable in most. The defining milestone is the hepatitis B vaccine. Where infant vaccination has been scaled up, chronic hepatitis B infection and liver cancer rates have been falling steadily for decades. But protection is not universal: many children still miss the first dose, and coverage remains uneven. The vaccine cannot undo an existing infection, and while small early-stage tumors can be removed or ablated, those options are not available everywhere. The clearest pathway remains preventing the virus in the first place.
- Does hepatitis B vaccination prevent liver cancer?
- Yes. Most liver cancer caused by hepatitis B starts with chronic infection. The hepatitis B vaccine prevents that infection when given before exposure. In countries with high infant vaccination coverage, liver cancer rates have fallen substantially. Vaccination does not help after infection is already present.
- Why is liver cancer from hepatitis B called "curable or preventable in most" if many liver cancers are not curable?
- The classification comes from the underlying risk. The hepatitis B vaccine can prevent the chronic infection that later causes most of these cancers. For someone already infected, prevention is no longer possible, and late-stage liver cancer remains difficult to cure.
- What has changed in recent decades?
- The hepatitis B vaccine has changed the disease trajectory. Countries with high childhood vaccination rates have seen chronic hepatitis B infections fall steadily and liver cancer rates follow. The decline continues in vaccinating communities, but many infants worldwide still miss the vaccine.
- Once liver cancer is present, can it still be cured?
- In a few cases, small early-stage liver tumors can be surgically removed or ablated. Most liver cancers found later are not curable. That is why preventing hepatitis B infection is the strongest public health opportunity.
- Are there experimental trials for liver cancer related to hepatitis B?
- As of this atlas dataset, no interventional trial for this disease combination is on record. Progress is still driven mainly by vaccination and by early detection of chronic hepatitis B-related cancers.